Diteba
Diteba is a privately held Canadian contract research organization founded in 2004 that provides GMP/GLP-compliant analytical, bioanalytical, IVRT/IVPT, biologics, stability, and QC testing services to pharmaceutical and nutraceutical companies seeking FDA, Health Canada, and EMA regulatory support.
- Company typePrivate
- Founded2004
- HeadquartersMississauga, Canada
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Diteba does
Diteba Inc. is a privately held contract research organization (CRO) founded in 2004 and headquartered in a 27,000 sq ft GMP/GLP-compliant laboratory facility in Mississauga, Ontario, Canada. The company delivers analytical and bioanalytical testing services to pharmaceutical and nutraceutical clients across the full drug development lifecycle, from early R&D method development through commercial and post-approval stability studies. Its service portfolio spans nine interconnected lines: Analytical Services, Bioanalytical Services, Biologics (oligonucleotides, peptides, proteins, polysaccharides), In Vitro Release Testing (IVRT) and In Vitro Permeation Testing (IVPT) for topical and transdermal products, QC Release Testing, Stability Testing, GMO Testing via Droplet Digital PCR, and Omega-3 Testing.
The laboratory is equipped with Waters chromatography (Alliance 2690 HPLC, ACQUITY UPLC), Waters mass spectrometry systems (ACQUITY TQD, Xevo TQ-S, QToF MS), ELISA-based bioanalytical platforms, Franz Cell and Enhanced Cell IVRT/IVPT systems, and a Waters NuGenesis SDMS data management environment with electronic audit trails. The facility features dual-laboratory redundancy, gas-powered generator and UPS backup, and a fully validated environmental monitoring system supporting continuous long-duration stability studies. Diteba is licensed by Health Canada (DEL, Controlled Substance Licence, Precursor Licence), registered with the FDA (inspected 2019, remotely audited 2023), compliant with EMA and ICH guidelines, and pursuing ISO 17025 accreditation.
Diteba generates revenue on a project-based, quote-driven professional services model, with pricing determined by service scope, regulatory complexity, sample volume, and contract duration, including multi-year stability and bioequivalence programs. Customers engage directly via phone, email, and sample submission, with services delivered globally to pharmaceutical and nutraceutical companies seeking FDA, Health Canada, and EMA-aligned testing and regulatory support. The company has stated it has supported "hundreds of companies" in navigating FDA approval over 20+ years and holds a documented FDA Bioequivalence approval for Penciclovir Cream 1% via an IVPT study.
Diteba firmographics
Firmographics- Name
- Diteba
- Legal name
- Diteba Inc.
- Website
- https://diteba.com
- Company type
- Private
- Founded year
- 2004
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Diteba is a privately held Canadian contract research organization founded in 2004 that provides GMP/GLP-compliant analytical, bioanalytical, IVRT/IVPT, biologics, stability, and QC testing services to pharmaceutical and nutraceutical companies seeking FDA, Health Canada, and EMA regulatory support.
- Ownership category
- akta.pro rank
Diteba industry classification
Industry- Product category
- Contract Research Organization (CRO) / Pharmaceutical Testing Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)
- akta.pro secondary industries
- Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB), Clinical CROs (Phase I–IV) (HLAGAAAA)
Keywords
Where Diteba is headquartered
LocationHeadquarters
- HQ city
- Mississauga
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
Diteba business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Infrastructure, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Contract Research and Testing Services: Diteba generates revenue through providing specialized analytical and bioanalytical testing services on a contract/project basis. Services include method development, validation, sample analysis, stability testing, QC release testing, and specialized testing (IVRT, IVPT, GMO, Omega-3). Revenue is project-based with pricing determined by scope, complexity, and regulatory requirements.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom project-based pricing based on service scope |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
Diteba product offering
Product offeringCore offering
Diteba is a contract research organization (CRO) that provides analytical and bioanalytical testing services to pharmaceutical and nutraceutical companies. Services include method development and validation, stability testing, QC release testing, bioequivalence studies, and specialized topical formulation testing (IVRT/IVPT) at a 27,000 sq ft GMP/GLP-compliant laboratory in Mississauga, Ontario. The company supports drug development from early R&D through commercial and post-approval stages under FDA, Health Canada, EMA, and ICH regulatory frameworks.
Product overview
Diteba is a pharmaceutical and nutraceutical contract research organization (CRO) providing analytical and bioanalytical testing services. The company operates a 27,000 square foot GMP/GLP-compliant laboratory facility in Mississauga, Ontario, Canada. Their service portfolio is organized as distinct but interconnected testing service lines covering the full drug development lifecycle: Analytical Services and Bioanalytical Services serve as the core offerings, supplemented by specialized services including Biologics (for large molecules), IVRT/IVPT (for topical drug products), QC Release Testing, Stability Testing, GMO Testing, and Omega-3 Testing. Services are delivered under cGMP/cGLP compliance with FDA, Health Canada, EMA, and ICH regulatory frameworks. The company also provides regulatory support for FDA and Health Canada submissions.
Differentiator
Problem solved
Functional benefit
Products and services
- Analytical Services Comprehensive analytical testing services supporting small and large molecule drug substance and product analysis, including method development, validation, stability programs, IVRT/IVPT studies, wet chemistry testing, dissolution tests, method transfer, and residual solvent testing for pharmaceutical and nutraceutical companies.
- Bioanalytical Services
- Biologics Services
- In Vitro Release Testing (IVRT)
- In Vitro Permeation Testing (IVPT)
- QC Release Testing
- Stability Testing
- GMO Testing
- Omega-3 Testing
Quantifiable outcome
- Successfully assisted pharmaceutical clients with ANDA submissions through IVRT and IVPT expertise with FDA approval for Penciclovir Cream 1% IVPT study
- +1 more outcomes
Companies that use Diteba
Customer profileSegments3 records
Ideal customer profiles3 records
Diteba technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Diteba partnerships and signals
Strategic signalScale indicators4 records
Recent moves4 records
Expansion highlights5 records
Diteba competitors and assessment
Company assessmentBroad incumbents
- Charles River Laboratories: Major CRO offering bioanalytical, preclinical, and manufacturing services. Comparable because Charles River competes in the same bioanalytical/biopharmaceutical testing space that Diteba serves, but with significantly broader capabilities and global footprint.
- SGS Health & Nutrition: Global testing services provider with pharmaceutical and nutraceutical testing capabilities. Comparable because SGS offers pharmaceutical analytical testing, nutraceutical quality testing, GMO testing, and Omega-3 testing services that overlap with Diteba's portfolio.
- IQVIA: World's largest clinical research services and biopharmaceutical analytics provider. Comparable because IQVIA's laboratory services arm competes in the central lab and bioanalytical testing markets that Diteba serves, though IQVIA offers much broader clinical and data services.
- Intertek Pharmaceutical Services: Global quality assurance and testing provider with pharmaceutical and nutraceutical laboratory services. Comparable because Intertek offers analytical testing, stability, GMP release, and nutraceutical testing that directly overlaps Diteba's service portfolio.
- WuXi AppTec: Global CRO/CDMO providing laboratory testing, bioanalytical, and biologics services. Comparable as a broader incumbent competing in Diteba's analytical and biologics testing space, but with much wider capabilities across discovery, development, and manufacturing.
- Eurofins Scientific: Global leader in bioanalytical, pharmaceutical, and clinical testing services. Comparable because Eurofins competes directly with Diteba in pharmaceutical analytical testing, bioequivalence, and stability studies, but at vastly greater scale and across a broader service portfolio.
- Labcorp Drug Development (Covance): Major CRO and central laboratory operator with bioanalytical and bioequivalence service lines. Comparable because Labcorp's early development services overlap with Diteba's bioanalytical and analytical testing, including bioequivalence work for generic drugs.
Direct peers
- Altasciences: Canadian-headquartered CRO providing bioanalytical, preclinical, and clinical research services. Comparable as a direct peer and regional competitor offering overlapping bioanalytical and bioequivalence services from Canada to similar pharma client segments.
- Bioanalytical Systems Inc. (BASi): Specialty CRO focused on bioanalytical and drug metabolism services. Comparable as a direct peer because BASi provides small- and large-molecule bioanalytical testing, PK studies, and contract research services to pharmaceutical clients in a similar niche to Diteba.
- Celerion: Early-phase clinical and bioanalytical CRO specializing in PK/PD, bioequivalence, and first-in-human studies. Comparable because Celerion operates in the same bioanalytical and bioequivalence testing niche that Diteba serves, particularly for generic drug programs.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
Diteba social profiles
Digital presenceDiteba compliance and trust
Trust signalCompliance4 records
Diteba financial estimates
Financial estimateRevenue estimate
Valuation estimate
Diteba leadership team
Management profileNumber of profiles
Profiles1 record
Diteba funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Diteba M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Diteba
What does Diteba do?
Diteba is a contract research organization (CRO) that provides analytical and bioanalytical testing services to pharmaceutical and nutraceutical companies. Services include method development and validation, stability testing, QC release testing, bioequivalence studies, and specialized topical formulation testing (IVRT/IVPT) at a 27,000 sq ft GMP/GLP-compliant laboratory in Mississauga, Ontario. The company supports drug development from early R&D through commercial and post-approval stages under FDA, Health Canada, EMA, and ICH regulatory frameworks.
Is Diteba a public or private company?
Diteba is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Diteba founded?
Diteba was founded in 2004. It employs 11 to 50 people.
Where is Diteba based?
Diteba is headquartered in Mississauga, Canada, in the North America region.
How does Diteba make money?
One revenue line is on record: contract Research and Testing Services.
Who are Diteba's main competitors?
Broad incumbents on record are Charles River Laboratories, SGS Health & Nutrition, IQVIA, Intertek Pharmaceutical Services, WuXi AppTec, Eurofins Scientific and Labcorp Drug Development (Covance). Direct peers are Altasciences, Bioanalytical Systems Inc. (BASi) and Celerion.
Does Diteba have an API?
No public API is recorded for Diteba.
What industry is Diteba in?
Diteba's product category is Contract Research Organization (CRO) / Pharmaceutical Testing Services. Its primary akta.pro industry code is HLAGAAAE, Central Laboratory & Clinical Trial Testing CROs, with a secondary code of HLAGAAAB, Preclinical CROs (Discovery/Pharmacology/DMPK). Its NAICS code is 5417 and its SIC code is 8731.